Medicines for relieving intestinal disorders

Details Medicines for relieving intestinal disorders Medicines for relieving intestinal disorders

2006-04-18

2006-04-18

Wax, Robert A. (Department: 1651)

Drug, bio-affecting and body treating compositions

Whole live micro-organism, cell, or virus containing

Bacteria or actinomycetales

C435S252900, C435S078000, C514S892000

Reexamination Certificate

active

07029670

ABSTRACT:
An agent for relieving intestinal disorders which contain live cells of a strain belonging toLactobacillus helveticus. This strain is preferably characterized by a resistance to a specific bile acid, adhesiveness to intestinal epithelial cells, etc. A method of controlling intestinal functions which involves the step of administering such a medicine to a subject with a need for the control of intestinal functions. When administered to humans or the like, these agents exert effects of elevating defecation frequency, etc., thereby efficaciously improving the intestinal environment.

REFERENCES:
patent: 3846560 (1974-11-01), Hempenius et al.
patent: 3876806 (1975-04-01), Hempenius et al.
patent: 4107334 (1978-08-01), Jolly
patent: 4293571 (1981-10-01), Olofsson et al.
patent: 4585757 (1986-04-01), Pang et al.
patent: 4687739 (1987-08-01), Sugisawa et al.
patent: 4687840 (1987-08-01), Pang et al.
patent: 4980164 (1990-12-01), Manfredi et al.
patent: 5238921 (1993-08-01), Maruyama et al.
patent: 5314873 (1994-05-01), Tomita et al.
patent: 5409718 (1995-04-01), Klaver et al.
patent: 5418218 (1995-05-01), Wilber
patent: 5466472 (1995-11-01), Kuma et al.
patent: 5486461 (1996-01-01), Nielsen
patent: 5547687 (1996-08-01), Outinen et al.
patent: 5618689 (1997-04-01), McCarthy et al.
patent: 5656268 (1997-08-01), Sorodsky
patent: 5766940 (1998-06-01), Yamamoto
patent: 6214585 (2001-04-01), Kwon et al.
patent: 6221423 (2001-04-01), Cho et al.
patent: 6372282 (2002-04-01), Edens et al.
patent: 2002/0132288 (2002-09-01), Swamylingappa et al.
patent: 2002/0182301 (2002-12-01), Draaisma et al.
patent: 2003/0027769 (2003-02-01), Scialdone et al.
patent: 2003/0040475 (2003-02-01), Toba et al.
patent: 2003/0072863 (2003-04-01), Hayasawa et al.
patent: 5 528 (1967-11-01), None
patent: 05-236872 (1993-09-01), None
patent: 05-292947 (1993-11-01), None
patent: 07-255467 (1995-10-01), None
patent: 09-002959 (1997-01-01), None
patent: 03-251159 (1997-11-01), None
patent: 10-146157 (1998-06-01), None
patent: 11-239476 (1999-09-01), None
patent: 2000-197469 (2000-07-01), None
patent: WO-01/68113 (2001-09-01), None
patent: WO-01/68114 (2001-09-01), None
Yamamoto et al., Isolation and characterization of a plasmid fromLactobacillus helveticusCP53, Biosci Biotech Biochem 60(12):2069-2070, 1996.
Karine Thoreux, et al., “Modulation of proliferation, second messenger levels, and morphotype expression of the rat intestinal epithelial cell line IEC-6 by fermented milk”, J-Dairy-Science, Jan. 1996, vol. 79-pp. 33-43.
Jiang Hanqing, et al., “Preliminary Research on the Adjustment of Intestinal Dysbacteriosis byBifidobacteriumandLactobacillusin Rats”, 1995, pp. 32-34.
Chuanbin Wang, et al., “Screening and Studying on Biological Characteristics of Lactobacilli of Animal Origin”, Journal of Jiangsu Agricultural College, Dec. 3, 1996, vol. 18, No. 1, pp. 1-5.
Naoyuki Yamamoto et al., “Isolation and characterization of a plasmid fromLactovacillus helveticusCP53”, Bioscience, Biotechnology, and Biochemistry, Dec. 1996, vol. 60, pp. 2069-2070.
Chandan, R.C., “Enhancing Market Value of Milk by Adding Cultures”, J. Dairy Sci., vol. 82, pp. 2245-2256 (1999).
Kontula, P., et al., “The Effect of Lactose Derivatives on Intestinal Lactic Acid Bacteria”, J. Diary Sci., vol. 82, pp. 249-256 (1999).
Alander, Minna, et al., “Persistence of Colonization of Human Colonic Mucosa by a Probiotic Strain,Lactobacillus rhamnosusGG, after Oral Consumption”, Applied and Environmental Microbiology, Jan. 1999, vol. 65, No. 1, pp. 351-354.
Biosciences and Industry, Susumu Maruyama, “Production of Hypotensive Peptides from Food Protein”, 47 No. 11, 38-42, 1989. (with partial translation).
Japan Fermentation Engineering Society, Susumu Maruyama, et al. “Production of Peptide Inhibitors of the Renin-Angiotensin System from Maize Protein”, p. 23, 1988.
Japanese Society for Bioscience, Biotechnology and Agrochemistry, Susumu Maruyama, et al., “Angiotensin Converting Enzyme Inhibitory Effect and Hypotensive Effect of Peptides from Repeat Sequence Region of Corn Seed Protein”, p. 8, 1989.
Japan Nutrition and Food Society, Shinsuke Miyoshi, et al., “Hypotensive Effect of Enzymolytic Product of Maize Protein on SHR”, p. 113, 1989.
Journal of Japan Agricultural Chemistry Society, Shinsuke Miyoshi, et al., “Angiotensin Converting Enzyme Inhibitory Effect of Peptides Derived from Maize Protein”, 64(3), 555, 1990. (translation).
Antonie van Leeuwenhoek, “The Proteolytic Systems of Lactic Acid Bacteria,” 70: 187-221. 1996.

Affiliated with

Also associated with

Rating

Medicines for relieving intestinal disorders does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Medicines for relieving intestinal disorders, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Medicines for relieving intestinal disorders will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3556263